An automated blood test for glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) to predict the absence of intracranial lesions on head CT in adult patients with mild traumatic brain injury: BRAINI, a multicentr
This study is co-funded by the European Institute of Innovation and Technology (EIT) Health, a body of the European Union (Grant nº19474). Biomarkers tests were funded by bioMérieux.
Authors
- Alfonso Lagares
- Hugo Terrisse (ORCID: https://orcid.org/0000-0001-8239-1903)
- Javier de la Cruz (ORCID: https://orcid.org/0000-0002-2010-4128)
- Céline Vermorel
- Odile Méjan
- Jean‐François Payen (ORCID: https://orcid.org/0000-0001-8400-3839)
- Vladislav Pavlov (ORCID: https://orcid.org/0000-0002-2942-6393)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Zimmer Biomet (Netherlands) (NL)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Research Institute Hospital 12 de Octubre (ES)
- Hospital Universitario 12 De Octubre (ES)
- bioMérieux (France) (FR)
- Grenoble Institute of Neurosciences (FR)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- EBioMedicine
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1016/j.ebiom.2024.105477
- Citations
- 17
- Primary Topic
- Traumatic Brain Injury and Neurovascular Disturbances
- Type
- article
- Field-Weighted Citation Impact
- 6.28
Funders
- European Commission
- European Institute of Innovation and Technology